Market Value6,631,817,000
Total Holdings82
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IGMS / IGM Biosciences, Inc.
INBX.V / Inhibrx, Inc.
RLAY / Relay Therapeutics, Inc.
SCPH / scPharmaceuticals Inc.
SPRY / ARS Pharmaceuticals, Inc.
BOLT / Bolt Biotherapeutics, Inc.
STSA / Satsuma Pharmaceuticals Inc
/ Pandion Therapeutics Inc
CCCC / C4 Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
RPTX / Repare Therapeutics Inc.
OVID / Ovid Therapeutics Inc.
PRDS / Pardes Biosciences Inc
US2103731061 / Constellation Pharmaceuticals Inc
PHAT / Phathom Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
BLSA / BCLS Acquisition Corp - Class A
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
PACB / Pacific Biosciences of California, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
ETNB / 89bio, Inc.
PASG / Passage Bio, Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
AKUS / Akouos Inc
HLXA / Helix Acquisition Corp - Class A
SNDX / Syndax Pharmaceuticals, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
ADVM / Adverum Biotechnologies, Inc.
US33830X1046 / Five Prime Therapeutics Inc
MRNS / Marinus Pharmaceuticals, Inc.
PROF / Profound Medical Corp.
MCRB / Seres Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
FLACU / Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
ORIC / ORIC Pharmaceuticals, Inc.
NAUT / Nautilus Biotechnology, Inc.
CRIS / Curis, Inc.
TNGX / Tango Therapeutics, Inc.
MGNX / MacroGenics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
PMVP / PMV Pharmaceuticals, Inc.
/ Cerevel Therapeutics Holdings, Inc. Warrant
STRO / Sutro Biopharma, Inc.
INZY / Inozyme Pharma, Inc.
OLMA / Olema Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
IKNA / Ikena Oncology, Inc.
TXMD / TherapeuticsMD, Inc.
FVAM / 5:01 Acquisition Corp.
KROS / Keros Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
CRDF / Cardiff Oncology, Inc.
WVE / Wave Life Sciences Ltd.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
AVIR / Atea Pharmaceuticals, Inc.
IMGN / ImmunoGen, Inc.
VOR / Vor Biopharma Inc.
KNTE / Kinnate Biopharma Inc.
HSAQ / Health Sciences Acquisitions Corp 2
ALEC / Alector, Inc.
SLDB / Solid Biosciences Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
CNCE / Concert Pharmaceuticals Inc
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
XFOR / X4 Pharmaceuticals, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
ARDX / Ardelyx, Inc.
OCUL / Ocular Therapeutix, Inc.
TGTX / TG Therapeutics, Inc.
KALA / KALA BIO, Inc.
TRIL / Trillium Therapeutics Inc
TIL / Instil Bio, Inc.
CCXI / ChemoCentryx Inc
PRQR / ProQR Therapeutics N.V.
MIST / Milestone Pharmaceuticals Inc.
SYRS / Syros Pharmaceuticals, Inc.
FMTX / Forma Therapeutics Holdings Inc
NVAX / Novavax, Inc.
CTMX / CytomX Therapeutics, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
TVTX / Travere Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
DSGN / Design Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
ARVN / Arvinas, Inc.
VXRT / Vaxart, Inc.
NKTX / Nkarta, Inc.
VRDN / Viridian Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
COGT / Cogent Biosciences, Inc.
AXSM / Axsome Therapeutics, Inc.
GERN / Geron Corporation
PCVX / Vaxcyte, Inc.